H2AX deficiency is associated with erythroid dysplasia and compromised haematopoietic stem cell function

Scientific Reports
Baobing ZhaoPeng Ji

Abstract

Myelodysplastic syndromes (MDS) are clonal disorders of haematopoiesis characterised by dysplastic changes of major myeloid cell lines. However, the mechanisms underlying these dysplastic changes are poorly understood. Here, we used a genetically modified mouse model and human patient data to examine the physiological roles of H2AX in haematopoiesis and how the loss of H2AX contributes to dyserythropoiesis in MDS. H2AX knockout mice showed cell-autonomous anaemia and erythroid dysplasia, mimicking dyserythropoiesis in MDS. Also, dyserythropoiesis was increased in MDS patients with the deletion of chromosome 11q23, where H2AX is located. Although loss of H2AX did not affect the early stage of terminal erythropoiesis, enucleation was decreased. H2AX deficiency also led to the loss of quiescence of hematopoietic stem and progenitor cells, which dramatically compromised their bone marrow engraftment. These results reveal important roles of H2AX in late-stage terminal erythropoiesis and hematopoietic stem cell function.

References

May 18, 2001·Nature·J H Hoeijmakers
Mar 15, 2002·Current Opinion in Genetics & Development·Christophe RedonWilliam Bonner
Apr 6, 2002·Science·Arkady CelesteAndré Nussenzweig
Apr 12, 2003·Developmental Cell·Oscar Fernandez-CapetilloAndré Nussenzweig
Aug 14, 2003·Cell·Arkady CelesteAndré Nussenzweig
Jun 8, 2007·Nature·Anastasia NijnikRichard J Cornall
Feb 12, 2008·Nature Cell Biology·Peng JiHarvey F Lodish
Feb 26, 2008·Cell·Derrick J RossiIrving L Weissman
Apr 17, 2008·Annals of Hematology·Detlef Haase
Jun 3, 2008·Blood Cells, Molecules & Diseases·Elizabeth A Price
Feb 24, 2009·Nature·Peter J CookMichael G Rosenfeld
Mar 20, 2009·Journal of Visualized Experiments : JoVE·Rushdia Z Yusuf, David T Scadden
Aug 27, 2009·Chromosoma·Jennifer S DickeyWilliam M Bonner
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ke ChenNarla Mohandas
Apr 3, 2010·Hematology/oncology Clinics of North America·Jean-Pierre Issa
May 18, 2010·Expert Review of Anticancer Therapy·Sean M Post, Alfonso Quintás-Cardama
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rafael BejarBenjamin L Ebert
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Jun 15, 2012·American Journal of Hematology·Guillermo Garcia-Manero
Sep 1, 2012·Annual Review of Pathology·R Coleman Lindsley, Benjamin L Ebert
Jul 6, 2013·Cell·Emily M HatchMartin W Hetzer
Dec 17, 2014·Cell Death and Differentiation·J FarrésJ Yélamos

❮ Previous
Next ❯

Methods Mentioned

BETA
MDS
PCR
flow cytometry

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.